# JSS Sustainable Equity - Future Health (continued)
| Description | % | Expiry/ | Currency | Initial holding | Purchases* | Sales* | Closing holding | Market value in | % of |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  | Maturity |  | on 01.05.2022 |  |  | on 31.10.2022 | USD | net assets |
| Natera Inc |  |  | USD | 35 404 | 16 176 | -51 580 | - | - | 0.00 |
| Neurocrine Biosciences Inc |  |  | USD | 44 070 | 4 231 | - | 48 301 | 5 560 411.12 | 2.03 |
| Nike Inc B |  |  | USD | 46 510 | - | -46 510 | - | - | 0.00 |
| Novartis Ag Basel/Nam. |  |  | CHF | - | 65 518 | -31 557 | 33 961 | 2 745 387.06 | 1.00 |
| Novavax --- Registered Shs |  |  | USD | - | 60 694 | -60 694 | - | - | 0.00 |
| Novo Nordisk A/S B |  |  | DKK | 85 157 | 3 349 | -63 218 | 25 288 | 2 749 848.95 | 1.00 |
| Pfizer Inc. |  |  | USD | - | 120 484 | - | 120 484 | 5 608 530.20 | 2.05 |
| Planet Fitness Inc |  |  | USD | 76 708 | - | -76 708 | - | - | 0.00 |
| Qiagen N.V. |  |  | EUR | - | 59 904 | - | 59 904 | 2 587 307.37 | 0.95 |
| R1 Rcm Rg |  |  | USD | - | 137 292 | - | 137 292 | 2 424 576.72 | 0.89 |
| Roche Holding Ag /Genussschein |  |  | CHF | 22 044 | 12 223 | -7 378 | 26 889 | 8 935 239.44 | 3.27 |
| Sanofi |  |  | EUR | 84 927 | 36 286 | -55 804 | 65 409 | 5 645 621.21 | 2.06 |
| Sarepta Therapeutics Inc |  |  | USD | 31 288 | 3 004 | - | 34 292 | 3 909 973.84 | 1.43 |
| Seagen Rg |  |  | USD | - | 47 763 | - | 47 763 | 6 073 543.08 | 2.22 |
| Takeda Pharmaceutical Co Ltd |  |  | JPY | - | 195 600 | - | 195 600 | 5 155 991.16 | 1.89 |
| Tandem Diabetes Care Inc |  |  | USD | - | 48 496 | - | 48 496 | 2 723 050.40 | 0.99 |
| Tecan Group Sa /Nam. |  |  | CHF | - | 6 760 | - | 6 760 | 2 481 763.77 | 0.91 |
| Teladoc Inc |  |  | USD | 51 286 | - | -51 286 | - | - | 0.00 |
| Teleflex Inc |  |  | USD | 22 627 | - | -22 627 | - | - | 0.00 |
| Thermo Fisher Scientific Inc |  |  | USD | 21 713 | 1 389 | -23 102 | - | - | 0.00 |
| Transmedics Group Inc |  |  | USD | - | 135 848 | -135 848 | - | - | 0.00 |
| Ucb |  |  | EUR | 68 636 | 25 730 | - | 94 366 | 7 118 109.67 | 2.60 |
| Unitedhealth Group Inc |  |  | USD | 38 166 | 3 664 | -8 943 | 32 887 | 18 257 218.05 | 6.68 |
| Veeva Systems Inc |  |  | USD | 16 363 | - | -16 363 | - | - | 0.00 |
| Vertex Pharmaceuticals |  |  | USD | 17 234 | 21 680 | -8 187 | 30 727 | 9 586 824.00 | 3.51 |
| Zoetis Inc -A- |  |  | USD | 22 070 | - | -22 070 | - | - | 0.00 |
|  |  |  |  |  |  |  |  | 270 245 923.58 | 98.84 |

| Total - Transferable securities admitted to an official stock exchange listing | 270 245 923.58 | 98.84 |
| --- | --- | --- |
|  |  |  |
| TOTAL SECURITIES PORTFOLIO INVESTMENTS | 270 245 923.58 | 98.84 |
| Liquidities and deposits (net) | 6 746 057.59 | 2.47 |
| Other assets and liabilities | -3 572 773.45 | -1.31 |
|  |  |  |
| TOTAL NET ASSETS | 273 419 207.72 | 100.00 |

* Purchases and sales (unaudited) include the following transactions:
Exercising of subscription/option rights/conversions/name changes/stock splits/transfers/switching between companies/free units/purchases/splits/stock/elective dividends/exit following expiry/drawing of lots/reverse splits/redemptions/disposals.

Translation (ENDE, 2022-10-31):
# JSS Sustainable Equity - Future Health (Fortsetzung)
| Bezeichnung | % | Verfall/ Fälligkeit | Währung | Anfangs- bestand 01.05.2022 | Käufe* | Verkäufe* | Schluss- bestand 31.10.2022 | Marktwert in USD | % des Netto- vermögens |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Moderna Inc |  |  | USD | - | 7 390 | - | 7 390 | 1 110 938.70 | 0.41 |
| Natera Inc |  |  | USD | 35 404 | 16 176 | -51 580 | - | - | 0.00 |
| Neurocrine Biosciences Inc |  |  | USD | 44 070 | 4 231 | - | 48 301 | 5 560 411.12 | 2.03 |
| Nike Inc B |  |  | USD | 46 510 | - | -46 510 | - | - | 0.00 |
| Novartis Ag Basel/Nam. |  |  | CHF | - | 65 518 | -31 557 | 33 961 | 2 745 387.06 | 1.00 |
| Novavax --- Registered Shs |  |  | USD | - | 60 694 | -60 694 | - | - | 0.00 |
| Novo Nordisk A/S B |  |  | DKK | 85 157 | 3 349 | -63 218 | 25 288 | 2 749 848.95 | 1.00 |
| Pfizer Inc. |  |  | USD | - | 120 484 | - | 120 484 | 5 608 530.20 | 2.05 |
| Planet Fitness Inc |  |  | USD | 76 708 | - | -76 708 | - | - | 0.00 |
| Qiagen N.V. |  |  | EUR | - | 59 904 | - | 59 904 | 2 587 307.37 | 0.95 |
| R1 Rcm Rg |  |  | USD | - | 137 292 | - | 137 292 | 2 424 576.72 | 0.89 |
| Roche Holding Ag /Genussschein |  |  | CHF | 22 044 | 12 223 | -7 378 | 26 889 | 8 935 239.44 | 3.27 |
| Sanofi |  |  | EUR | 84 927 | 36 286 | -55 804 | 65 409 | 5 645 621.21 | 2.06 |
| Sarepta Therapeutics Inc |  |  | USD | 31 288 | 3 004 | - | 34 292 | 3 909 973.84 | 1.43 |
| Seagen Rg |  |  | USD | - | 47 763 | - | 47 763 | 6 073 543.08 | 2.22 |
| Takeda Pharmaceutical Co Ltd |  |  | JPY | - | 195 600 | - | 195 600 | 5 155 991.16 | 1.89 |
| Tandem Diabetes Care Inc |  |  | USD | - | 48 496 | - | 48 496 | 2 723 050.40 | 0.99 |
| Tecan Group Sa /Nam. |  |  | CHF | - | 6 760 | - | 6 760 | 2 481 763.77 | 0.91 |
| Teladoc Inc |  |  | USD | 51 286 | - | -51 286 | - | - | 0.00 |
| Teleflex Inc |  |  | USD | 22 627 | - | -22 627 | - | - | 0.00 |
| Thermo Fisher Scientific Inc |  |  | USD | 21 713 | 1 389 | -23 102 | - | - | 0.00 |
| Transmedics Group Inc |  |  | USD | - | 135 848 | -135 848 | - | - | 0.00 |
| Ucb |  |  | EUR | 68 636 | 25 730 | - | 94 366 | 7 118 109.67 | 2.60 |
| Unitedhealth Group Inc |  |  | USD | 38 166 | 3 664 | -8 943 | 32 887 | 18 257 218.05 | 6.68 |
| Veeva Systems Inc |  |  | USD | 16 363 | - | -16 363 | - | - | 0.00 |
| Vertex Pharmaceuticals |  |  | USD | 17 234 | 21 680 | -8 187 | 30 727 | 9 586 824.00 | 3.51 |
| Zoetis Inc -A- |  |  | USD | 22 070 | - | -22 070 | - | - | 0.00 |
|  |  |  |  |  |  |  |  | 270 245 923.58 | 98.84 |

| Summe - Übertragbare Wertpapiere, die an einer amtlichen Börse zugelassen sind | 270 245 923.58 | 98.84 |
| --- | --- | --- |
|  |  |  |
| SUMME WERTPAPIERBESTAND | 270 245 923.58 | 98.84 |
| Liquide Mittel inklusive Geldmarktanlagen | 6 746 057.59 | 2.47 |
| Sonstige Aktiven und Passiven | -3 572 773.45 | -1.31 |
|  |  |  |
| GESAMTNETTOVERMÖGEN | 273 419 207.72 | 100.00 |

*Käufe und Verkäufe (ungeprüft) umfassen die folgenden Transaktionen:
Ausübung von Bezugs-/Optionsrechten/Umwandlungen/Namensänderungen/Titelaufteilungen/Übertragungen/Umtausch zwischen Gesellschaften/Gratisanteile/Käufe/„Splits“/Aktien-/Wahldividenden/Ausgang infolge Verfall/Auslosungen/„Reversesplits“/Rückzahlungen/Verkäufe